Combination of H1-CCR5 shRNA 1005 and C46 into a single LV termed LVsh5/C46 (or Cal-1) has been tested in a preclinical trial discussed below and is currently being assessed in a Phase 1 trial in patients with chronic HIV-1 infection (NCT01734850). Here, CCR5 is linked to HIV-1 infection.